Lesson plan
Orphine
Orphine is a class of synthetic opioid analgesic drugs, first developed in the 1960s and 1970s by Paul Janssen but categorised as their own distinct grouping by international drug control agencies, such as the EUDA and UNODC in 2025. These have emerged as designer drugs in recent years following increasing legislative controls on earlier families of synthetic opioids such as fentanyls and nitazenes. Orphines are not structural analogues of morphine (known as morphinans), despite the similar name. Initially, the term referred to compounds such as brorphine and bezitramide (which are related to fentanyls, but with the aniline nitrogen cyclised into a benzimidazole ring system), but subsequently a second group of compounds also came to be referred to under this epithet, namely the spiropiperidine derivatives typified by spirochlorphine (R6890), where the 4-position of the piperidine ring is fused to an N-phenyl imidazole ring through a shared carbon atom. Judged by molecular structure these are distinct types, but they show a similar overlay in terms of their three-dimensional shape, and have similar structure-activity relationships and pharmacology. As with many other opioid drugs of this type, replacing the "tail" substitution on the piperidine with a p-fluorobutyrophenone produces antipsychotics instead of opioids (benperidol and spiperone respectively).…
Article summary
Orphine is a class of synthetic opioid analgesic drugs, first developed in the 1960s and 1970s by Paul Janssen but categorised as their own distinct grouping by international drug control agencies, such as the EUDA and UNODC in 2025. These have emerged as designer drugs in recent years following increasing legislative controls on earlier families of synthetic opioids such as fentanyls and nitazenes. Orphines are not structural analogues of morphine (known as morphinans), despite the similar name. Initially, the term referred to compounds such as brorphine and bezitramide (which are related to fentanyls, but with the aniline nitrogen cyclised into a benzimidazole ring system), but subsequently a second group of compounds also came to be referred to under this epithet, namely the spiropiperidine derivatives typified by spirochlorphine (R6890), where the 4-position of the piperidine ring is fused to an N-phenyl imidazole ring through a shared carbon atom. Judged by molecular structure these are distinct types, but they show a similar overlay in terms of their three-dimensional shape, and have similar structure-activity relationships and pharmacology. As with many other opioid drugs of this type, replacing the "tail" substitution on the piperidine with a p-fluorobutyrophenone produces antipsychotics instead of opioids (benperidol and spiperone respectively).…
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.